Pulmonary Rehabilitation

Similar documents
High Frequency Chest Wall Oscillating Devices (HFCWO) (Airway Clearance Systems)

POLICIES AND PROCEDURE MANUAL

MEDICAL POLICY SUBJECT: PULMONARY REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/ Rehabilitation

Anesthesia for Routine Gastrointestinal Endoscopic Procedures (Additional description)

Herniated Disc Treatment Non-covered Procedures

Intrathecal Opioid Therapy for Management of Chronic Pain

Continuous Glucose Monitoring (CGM)

Intravitreal Avastin (Bevacizumab)

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY

Eylea (aflibercept) Document Number: IC-0026

Krystexxa (pegloticase) Document Number: IC-0158

Tecentriq (atezolizumab) (Intravenous)

Imfinzi (durvalumab) (Intravenous)

Transcranial Magnetic Stimulation

Pulmonary Rehabilitation and Respiratory Therapy Services in the Physician Office Setting* Sam Birnbaum, BBA, CMPE; and Brian Carlin, MD, FCCP

Velcade (bortezomib) Document Number: IC-0137

Dates Reviewed: 12/2012, 3/2013, 6/2013, 9/2013, 11/2013, 12/2013, 3/2014, 6/2014, 9/2014, 12/2014,

Cyramza (ramucirumab) (Intravenous)

Home Pulse Oximetry for Infants and Children

Continuous Glucose Monitoring (CGM)

Rituxan Hycela (rituximab and hyaluronidase human) (Subcutaneous)

Cardiac Disease Screening Lipid Profile

Cardiac Disease Screening Lipid Profile

Vagus Nerve Stimulation (VNS)

Clinical Policy Title: Pulmonary rehabilitation

Treatment or Removal of Benign Skin Lesions

Colony Stimulating Factors: Zarxio (filgrastim sndz) (Subcutaneous/Intravenous)

Clinical Policy Title: Pulmonary rehabilitation

Document Number: IC I. Length of Authorization. Dosing Limits

Yervoy (ipilmumab) Last Review Date: 03/25/2014 Date of Origin: 11/28/2011. Prior Auth Available: Post-Service Edit:

Reduction Mammoplasty

Prior Authorization Review Panel MCO Policy Submission

Surgical Treatment for Achalasia

Trelstar (triptorelin) (Intramuscular)

Alimta (pemetrexed) Document Number: IC 0007

Erythropoiesis Stimulating Agents (ESAs): Aranesp (darbepoetin alfa) (Subcutaneous/Intravenous) *NON DIALYSIS* Document Number: IC 0242

Colony Stimulating Factors: Nivestym (filgrastim-aafi) (Subcutaneous/Intravenous)

Ilaris (canakinumab) (Subcutaneous)

sad EFFECTIVE DATE: POLICY LAST UPDATED:

Is there any evidence that multi disciplinary pulmonary rehabilitation impacts on quality of life?

Pulmonary Rehabilitation in Chronic Lung Disease; Components and Organization. Prof. Dr. Müzeyyen Erk Cerrahpaşa Medical Faculty Chest Disease Dept.

Definitions of chronic conditions used to define the number of serious comorbidities in the study.

Improving Access to Pulmonary Rehabilitation through MBS Rebate

PREMATURITY/ESTIMATED GESTATIONAL AGE

Respiratory Disease. Dr Amal Damrah consultant Neonatologist and Paediatrician

MedStar Health considers Cough Assist Devices medically necessary for the following indications:

Clinical Policy: Oxygen Therapy in the Home Reference Number: CP.MP.485

Trelstar Depot (triptorelin)

Subject: Pulmonary Rehabilitation for Chronic Pulmonary Diseases

Division of Pulmonary, Critical Care, and Sleep Medicine, Jacksonville, FL. Department of Internal Medicine, Wichita, KS

Outpatient Pulmonary Rehabilitation. Populations Interventions Comparators Outcomes Individuals: With moderate-tosevere.

Outpatient Pulmonary Rehabilitation

MedStar Health considers Continuous Home Pulse Oximetry medically necessary for the following indications:

Contractor Number 03201

Prolia /Xgeva (denosumab) Document Number: IC-0098

Kyphoplasty and Vertebroplasty

Center for Respiratory and Sleep Medicine COPD Chronic Disease Management Program

Breast Reconstruction Surgery after Mastectomy or Lumpectomy

Pulmonary Rehabilitation. Palmetto GBA, Jurisdiction 11 MAC Provider Outreach and Education

Clinical Policy Title: Cardiac rehabilitation

Simponi ARIA (golimumab) (Intravenous)

Pulmonary Rehabilitation in COPD-An Important Non-pharmacological Treatment

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

LCD for Omalizumab (Xolair ) (L29240)

MEDICAL POLICY SUBJECT: HOME AND COMMUNITY OXYGEN THERAPY

MEDICAL POLICY SUBJECT: HOME AND COMMUNITY OXYGEN THERAPY

Knee Cartilage Transplants

Update on Pulmonary Rehabilitation Programme. HA Convention Dr. Wong WY, Ida Haven of Hope Hospital 8 May 2018

Coding restrictive lung disease icd 10

Medicare Part C Medical Coverage Policy

Chronic Obstructive Lung Disease

InterQual Level of Care 2018 Index

Pulmonary Rehabilitation

(To be filled by the treating physician)

Drug prescriptions (Pharm) Exposure (36/48 months)

Negative Pressure Wound Therapy (NPWT) (Vacuum-Assisted Wound Closure)

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15

WF RESPIRATORY SYSTEM. RESPIRATORY MEDICINE

Pulmonary Rehabilitation

Clinical Policy: Heart-Lung Transplant Reference Number: CP.MP.132

Group B: Directed self-study Group C: Anatomy lab. Lecture: Structure and function of larynx. Lecture: Dead space & compliance of lungs

Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects

Sleep Apnea: Diagnosis and Treatment

MEDICAL POLICY. Proprietary Information of Excellus Health Plan, Inc. A nonprofit independent licensee of the BlueCross BlueShield Association

Present value cost-savings to Medicaid over 25 years

LCD Information Document Information LCD ID Number L30046

Office Spirometry Guide

LCD L B-type Natriuretic Peptide (BNP) Assays

Policy Specific Section: October 1, 2010 January 21, 2013

Cardiac and Pulmonary Rehab Update I have no disclosures. 2/18/2018. AACVPR MAC Liaison Task Force and AACVPR MAC Resource Group - MRG

Pulmonology Elective PL-1 Residents

Lung-Volume Reduction Surgery ARCHIVED

Lessons to be learned from cardiopulmonary rehabilitation

Outpatient Pulmonary Rehabilitation. Description

Session Guidelines. This is a 15 minute webinar session for CNC physicians and staff

Question by Question (QXQ) Instructions for the Pulmonary Diagnosis Form (PLD)

Pulmonary Rehabilitation Guidelines for Australia and New Zealand

Transcription:

Pulmonary Rehabilitation Date of Origin: 06/2005 Last Review Date: 10/25/2017 Effective Date: 10/25/2017 Dates Reviewed: 05/2006, 05/2007, 05/2008, 11/2009, 02/2011, 01/2012, 08/2013, 07/2014, 09/2015, 11/2016 Developed By: Medical Necessity Criteria Committee I. Description Pulmonary rehabilitation is a restorative and preventative process for patients who are diagnosed with a chronic pulmonary disease. Pulmonary rehabilitation programs utilize a multidisciplinary approach in the areas of exercise training, psychosocial support, education, and follow-up. The purpose of the program is to help individuals improve their quality of life and restore them to their highest possible functional capacity. II. Criteria: CWQI HCS-0057 A. Medically supervised outpatient pulmonary rehabilitation will be covered to plan limitations for 1 or more of the following conditions a. The patient has a diagnosis of chronic pulmonary disease and ALL of the following: i. The patient is referred by a board-certified pulmonologist or primary care physician who is actively involved in the patient s care. ii. The patient has been diagnosed with 1 or more of the following: 1. Emphysema 2. Asthma 3. Chronic Obstructive Pulmonary Disease 4. Cystic Fibrosis 5. Chronic Bronchitis 6. Asbestosis 7. Alpha-1 Antitrypsin Deficiency 8. Pneumoconiosis 9. Radiation Pneumonitis 10. Pulmonary Fibrosis 11. Fibrosing Alveolitis 12. Status Post Lung Resection 13. Ankylosing spondylitis 14. Muscular dystrophy 15. Guillain-Barre syndrome 16. Amyotrophic lateral sclerosis (ALS) 17. Sarcoidosis Moda Health Medical Necessity Criteria Pulmonary Rehabilitation Page 1/5

18. Bronchopulmonary dysplasia 19. Paralysis of the diaphragm 20. Other documented chronic lung disease or conditions that affect pulmonary function. iii. The patient has a reduction of exercise tolerance in the past thirty days which restricts the ability to perform activities of daily living iv. The patient does not have a recent history of smoking or has quit smoking for at least 3 months v. The patient has a moderate to moderately severe functional pulmonary impairment as evidenced by FEV1 at values 25-60% of that predicted (values below 25% indicate severe disease process; levels over 60% indicate normalization) vi. There are no other medical/psychological limitations such as uncontrolled congestive heart failure, acute MI within the last 6 months, uncontrolled arrhythmias, substance abuse, metastatic cancer, disabling stroke, severe pulmonary hypertension, active pulmonary infection, or dementia b. The patient is preoperative or postoperative lung transplant or reduction pneumoplasty c. Pulmonary rehabilitation is not being requested for any other indications as those are considered experimental and investigational because the clinical effectiveness other than the indications listed above has not been established. Limitations: A typical course of pulmonary rehabilitation is outpatient and extends for up to 6-8 weeks. Coverage of pulmonary rehabilitation may be subject to applicable plan limitations for short-term rehabilitation therapies. III. Information Submitted with the Prior Authorization Request: 1. The last six months of medical records from the ordering physician indicating diagnosis and current medical management. 2. Results of recent pulmonary function test Moda Health Medical Necessity Criteria Pulmonary Rehabilitation Page 2/5

IV. CPT or HCPC codes covered: (Note: list may not be all inclusive) Codes G0237 G0238 G0239 G0424 S9473 Description Therapeutic procedures to increase strength or endurance of respiratory muscles, face-to-face, one-on-one, each 15 minutes (includes monitoring) Therapeutic procedures to increase respiratory function, other an described by G0237, one-on-one, face-to-face, per 15 minutes (includes monitoring) Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, 2 or more individuals (includes monitoring) Pulmonary rehabilitation, including exercise (includes monitoring) one hour, per session, up to 2 sessions per day Pulmonary rehabilitation program, non-physician provider, per diem V. Annual Review History Review Date Revisions Effective Date 08/2013 Annual Review: Added table with review date, revisions, 08/28/2013 and effective date. 07/2014 Annual Review: No change 07/2014 09/2015 Annual review- added ICD-9 and ICD-10 codes, Medicare 09/23/2015 Reference 11/2016 Annual review: No change 11/30/2016 10/25/2017 Annual Review: Updated to new template, no changes 10/25/2017 VI. References 1. AARC Clinical Practice Guidelines: Pulmonary Rehabilitation. Respiratory Care 2002; 47(5):617-625 2. Casaburi R, Kukafka D, Copper C, et al. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005; 127:809-817. 3. Eaton T, Young P, Fergusson W, et al. Does early pulmonary rehabilitation reduce acute healthcare utilization in COPD patients admitted with an exacerbation? A randomized controlled study. Respirology. 2009;14(2):230-238. 4. Griffiths TL, Phillips CJ, Davies S, et al. Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation program. Thorax 2001; 56:779-784. 5. Ketelaars CA, Abu-Saad HH, Schlosser MA, et al. Long-term outcome of pulmonary rehabilitation in patients with COPD. Chest. 1997; 112:363-369. 6. Kang SW. Pulmonary rehabilitation in patients with neuromuscular disease. Yonsei Med J. 2006 Jun 30;47(3):307-14. 7. Man W, Polkey M, Donaldson N, et al. Community pulmonary rehabilitation after hospitalization for acute exacerbations of chronic obstructive pulmonary disease: randomized controlled study. BMJ, doi:10.1136/bmj.38258.662720.3a (published 25 October 2004). Moda Health Medical Necessity Criteria Pulmonary Rehabilitation Page 3/5

8. Puhan M, Scharplatz M, Trooster T, et al. Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality-a systematic review. Respiratory Research 2005, 6:54 9. Puhan M, Scharplatz M, Troosters T, et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2009;(1):CD005305. 10. Pulmonary Rehabilitation: Is it for you? The Cleveland Clinic Health Information Center. Accessed on February 22, 2011 at: www.clevelandclinic.org. 11. Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. Chest. 1997; 112(6):1630-1656. 12. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint AACP/AACVPR evidencebased clinical practice guidelines. Chest. 2007 May;131(5 Supple):4S-42S. 13. Ries AL, Make BJ, Reilly JJ. Pulmonary rehabilitation in emphysema. Proc Am Thorac Soc. 2008;5(4):524-529. 14. Rossi G, Florini F, Romagnoli M, et al. Length and clinical effectiveness of pulmonary rehabilitation in outpatients with chronic airway obstruction. Chest. 2005; 127:105-109. 15. Spruit MA, Wouters EF. New modalities of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Sports Med. 2007;37(6):501-518. 16. Tiep BL. Disease management of COPD with pulmonary rehabilitation. Chest 1997; 112:1630-1656 17. ZuWallack R, Hedges H. Primary care of the patient with chronic obstructive pulmonary diseasepart 3: Pulmonary rehabilitation and comprehensive care for the patient with chronic obstructive pulmonary disease. Am J Med. 2008;121(7 Suppl):S25-S32. 18. Centers for Medicare & Medicaid Services; National Coverage Determination (NCD) for Pulmonary Rehabilitation Services (240.8); Effective date 9/25/2007; Implementation Date 1/7/2008 19. Physician Advisors Appendix 1 Applicable Diagnosis Codes: Codes Description D86.0 Sarcoidosis of lung E84.0 Cystic fibrosis with pulmonary manifestations J41.0-J41.8 Simple and mucopurulent chronic bronchitis J43.0-J43.9 Emphysema J44.0-J44.9 Other chronic obstructive pulmonary disease J47.0-J47.9 Bronchiectasis J60 Coalworker's pneumoconiosis J62.0-J62.8 Pneumoconiosis due to dust containing silica 63.0-J63.6 Pneumoconiosis due to other inorganic dusts J64 Unspecified pneumoconiosis J66.0-J66.8 Airway disease due to specific organic dust J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapors Moda Health Medical Necessity Criteria Pulmonary Rehabilitation Page 4/5

J70.1 Chronic and other pulmonary manifestations due to radiation J70.9 Respiratory conditions due to unspecified external agent J84.01-J84.09 Alveolar and parieto-alveolar conditions J84.10 Pulmonary fibrosis, unspecified J84.89 Other specified interstitial pulmonary diseases J86.0 Pyothorax with fistula J98.2 Interstitial emphysema J98.4 Other disorders of lung M41.20 Other idiopathic scoliosis, site unspecified M45.9 Ankylosing spondylitis of unspecified sites in spine P27.0 Wilson-Mikity syndrome P27.1 Bronchopulmonary dysplasia originating in the perinatal period P27.8 Other chronic respiratory diseases originating in the perinatal period Z94.2 Lung transplant status Appendix 2 Centers for Medicare and Medicaid Services (CMS) Medicare coverage for outpatient (Part B) drugs is outlined in the Medicare Benefit Policy Manual (Pub. 100-2), Chapter 15, 50 Drugs and Biologicals. In addition, National Coverage Determination (NCD) and Local Coverage Determinations (LCDs) may exist and compliance with these policies is required where applicable. They can be found at: http://www.cms.gov/medicare-coverage-database/search/advanced-search.aspx. Additional indications may be covered at the discretion of the health plan. Medicare Part B Covered Diagnosis Codes (applicable to existing NCD/LCD): Jurisdiction(s): 5, 8 NCD/LCD Document (s): National Coverage Determination (NCD) Pulmonary Rehabilitation Services (240.8) https://www.cms.gov/medicare-coverage-database/details/ncddetails.aspx?ncdid=320&ncdver=1&docid=240.8&kq=true&bc=gaaaabaaaaaaaa%3d%3d& NCD/LCD Document (s): Medicare Part B Administrative Contractor (MAC) Jurisdictions Jurisdiction Applicable State/US Territory Contractor F (2 & 3) AK, WA, OR, ID, ND, SD, MT, WY, UT, AZ Noridian Healthcare Solutions, LLC Moda Health Medical Necessity Criteria Pulmonary Rehabilitation Page 5/5